Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma

NCT00055783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: apolizumab

Sponsor

Stanford University

Collaborators

[object Object]